Polycystic ovarian syndrome
Polycystic ovarian syndrome (PCOS) is a chronic anovulation syndrome associated with androgen excess. An alternative diagnostic term, hyperandrogenic anovulation (HA) has been proposed as more accurate and potentially less confusing (the ovarian feature is of multiple follicles, not cysts)13. At this stage, however, PCOS remains the term that is widely known and used.
The diagnosis is made on the combined clinical, biochemical and sonographic grounds. The revised 2003 ASRM/ESHRE Rotterdam consensus criteria 4 require two of the following three criteria for the diagnosis:
- oligo- or anovulation
- hyperandrogenism (clinical or biochemical) and
- follicle count on imaging
Subsequently, the Androgen Excess and PCOS society (AE-PCOS) 9 specified a similar set of criteria for diagnosing PCOS but added that PCOS should be seen primarily be seen as a disorder of androgen excess or hyperandrogenism. The criteria set forward was:
- the presence of hyperandrogenism (clinical and/or biochemical)
- ovarian dysfunction (oligo-anovulation and/or polycystic ovaries)
- exclusion of related disorders
The estimated prevalence is ~6% (range 4-8%) of women of reproductive age but this varies (up to 20%) depending on the diagnostic criteria used 11.
The classic triad of PCOS is:
In addition to this, patients may have infertility, acne, male pattern balding or biochemically show increased androgen levels.
Luteinizing hormone (LH) is usually increased and follicle stimulating hormone (FSH) can be normal or decreased 10.
Normally premenopausal LH:FSH is 1:1. In PCOS it may be >2:1 or >3:1.
Anti-Müllerian hormone (AMH) levels are generally increased.
- subfertility and recurrent pregnancy loss.
- long-term increased risk of
- type 2 diabetes
- cardiovascular disease
- endometrial cancer 6
- women with polycystic ovarian morphology are at increased risk of OHSS when undergoing IVF, regardless of whether they have PCOS15.
Current recommended sonographic criteria for multifollicular ovarian morphology:
- 25 or more follicles per ovary (superseding the earlier Rotterdam criteria of 12 or more follicles) 14
- increased ovarian size (>10 cc): less sensitive than the follicle number criteria, but has a role when image resolution does not allow accurate follicle count, e.g. transabdominal scanning, older equipment
Other morphological features include:
- hyperechoic central stroma
- peripheral location of follicles: which can give a string of pearl appearance
- follicles of similar size measuring 2-9 mm
The presence of a single PCO is sufficient to provide the diagnosis 2.
Ovaries may be normal in PCOS, and conversely, polycystic ovaries may be seen in women without the syndrome. Diagnosis requires correlation with features of hyperandrogenism and oligo-anovulation.
History and etymology
The syndrome was first described by I.F. Stein and M.L. Leventhal in 1935 7.
- 1. Weissleder R, Wittenberg J, Harisinghani MM et-al. Primer of Diagnostic Imaging, Expert Consult- Online and Print. Mosby. (2011) ISBN:0323065384. Read it at Google Books - Find it at Amazon
- 2. Balen AH, Laven JS, Tan SL et-al. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum. Reprod. Update. 9 (6): 505-14. doi:10.1093/humupd/dmg044 - Pubmed citation
- 3. Atiomo WU, Pearson S, Shaw S et-al. Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS). Ultrasound Med Biol. 2000;26 (6): 977-80. Ultrasound Med Biol (link) - Pubmed citation
- 4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004;81 (1): 19-25. Fertil. Steril. (link) - Pubmed citation
- 5. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J. Clin. Endocrinol. Metab. 2006;91 (3): 786-9. doi:10.1210/jc.2005-2501 - Pubmed citation
- 6. Balen A. Polycystic ovary syndrome and cancer. Hum. Reprod. Update. 7 (6): 522-5. doi:10.1093/humupd/7.6.522 - Pubmed citation
- 7. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–91
- 8. Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract. Res. Clin. Endocrinol. Metab. 2006;20 (2): 235-44. doi:10.1016/j.beem.2006.03.005 - Pubmed citation
- 9. Azziz R, Carmina E, Dewailly D et-al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 2009;91 (2): 456-88. doi:10.1016/j.fertnstert.2008.06.035 - Pubmed citation
- 10. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin. Reprod. Med. 2002;20 (4): 317-26. doi:10.1055/s-2002-36706 - Pubmed citation
- 11. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6: 1-13. doi:10.2147/CLEP.S37559 - Free text at pubmed - Pubmed citation
- 12. Lujan ME, Jarrett BY, Brooks ED et-al. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum. Reprod. 2013;28 (5): 1361-8. doi:10.1093/humrep/det062 - Pubmed citation
- 13. Martins WP, Kollmann M, Raine-Fenning N. Counting ovarian follicles: updated threshold for diagnosis of hyperandrogenic anovulation. Ultrasound Obstet Gynecol. 2014;44 (2): 131-4. doi:10.1002/uog.13402 - Pubmed citation
- 14. Dewailly D, Gronier H, Poncelet E et-al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum. Reprod. 2011;26 (11): 3123-9. doi:10.1093/humrep/der297 - Pubmed citation
- 15. Dewailly D, Lujan ME, Carmina E et-al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum. Reprod. Update. 2014;20 (3): 334-52. doi:10.1093/humupd/dmt061 - Pubmed citation